Introduction
In the past various methods have been used to treat polycythaemia which is secondary to lung disease in an attempt to lessen its harmful effects. Venesection occasionally gives some relief (Auchincloss and Duggan, 1957 ) but leads to a temporary increase in clotting tendency with an added risk of thrombosis and embolism. Continuous oxygen therapy has been successful in reducing red cell mass and packed cell volume (P.C.V.) with symptomatic benefit but ordinarily necessitates a hospital stay of about six weeks (Chamberlain and Millard, 1963) . Pyrimethamine with dapsone or phenylhydrazine has also been used and produced symptomatic improvement, but these drugs carry the risk of thrombocytopenia and overcorrection of the polycythaemia (Pengelly, 1966 (Pengelly, , 1969 .
A method of rapidly lowering red cell volume by using an isovolaemic exchange transfusion technique has recently been described (Gregory, 1971a) and initial results in patients with (Gregory, 1971b) . Further experience with the method is now reported.
Patients and Methods
Ten elective isovolaemic exchange transfusions were performed in eight patients with polycythaemia secondary to hypoxic lung disease. The technique (Gregory, 1971a) consists in the simultaneous intravenous infusion of dextran 40 in 5% dextrose into one arm and venesection from the other arm. The total volume of dextran infused is equal to the volume of blood venesected, but only half is given during the period of the venesection, because low-molecular-weight dextran attracts an additional volume of fluid equal to its own volume from the extravascular space into the circulation. The remaining dextran is given over the next 8 to 16 hours.
The reason for using dextran 40 is primarily because it is an effective plasma expander, and with this technique 2 litres of blood can be safely removed in about 45 minutes. It also has the theoretical advantages of reducing red cell aggregation and, because it is hypertonic and draws fluid into the vascular space from the interstitial space, of improving tissue capillary blood flow.
All eight patients had a long history of respiratory illness with several previous admissions to hospital; all except one (Case 5) had a history of ankle swelling and raised jugular venous pressure. Their clinical and other data are given in Table I . Chronic bronchitis was defined according to the Medical Research Council (1965) classification, and emphysema was diagnosed on posteroanterior and lateral chest radiographs, the criteria of Laws and Heard (1962) being used. In none had there been any change in the symptoms or signs of their pulmonary or cardiac condition in the week preceding the study, and the weight of each patient measured daily had remained steady during that week. Two patients (Cases 4 and 6) were admitted on two occasions for exchange transfusion.
Red cell volume was measured with chromium-51-labelled red cells and whole blood, and plasma volumes were either estimated indirectly from this (Cases 1-5) or measured directly with iodine-125-labelled albumin . Spirometry was performed with a water canister spirometer, and each patient had an E.C.G. and chest radiograph before and after exchange transfusion. Haemoglobin, P.C.V., and blood urea were also measured before and after each exchange. Progressive exercise tests were performed on a cycle ergometer by six patients before and after treatment. In Cases 2, 3, 4b, and 5 the object was to cycle for six minutes each at three increasing loads. In Cases 6 and 8 each load was continued for only one minute as this was found to provide a more satisfactory method for assessing changes. All post-treatment measurements and investigations were performed 3 to 11 days after exchange transfusion.
Results
The haemoglobin, P.C.V., red cell volume, plasma volume, whole blood volume, and blood viscosity, expressed as mean values for the group before and after exchange transfusion, are given in Fig. 1 with the individual exchanges. All the patients had a raised red cell volume before treatment, but the plasma volumes variedfive had normal values while three had reduced and two had a raised plasma volume. After exchange the fall in whole blood volume resulted largely from the fall in red cell volunXe except in one patient (Case 4b) in whom exchange transfusion was followed by a prolonged diuresis.
The changes in arterial gas tensions and carbon monoxide gas transfer are shown in Table II . There were no important changes in oxygen tension and no consistent changes in carbon (Figs. 3 and 4) . One patient (Case 5) who derived no subjective benefit from the treatment also showed the least objective improvement of those patients who performed the six-minute progressive exercise tests (Fig. 3) ceased pedalling because of exercise dyspnoea, and no exercise was stopped because of disproportionate tachycardia or dysrhythmia.
There were no adverse reactions to exchange transfusion, though several patients felt rather tired for 24 hours. Two patients (Cases 4 and 6) were readmitted for further exchange transfusions after six and two and a half months respectively and benefited as much from these as they had from their first. One patient (Case 2) was readmitted six weeks after exchange transfusion and died from cardiac and respiratory failure.
Discussion
The polycythaemia in patients with hypoxic lung disease is similar to the physiological response to hypoxia of normal subjects living at high altitudes. The red cell mass in both groups increases linearly with the fall in arterial oxygen saturation (Shaw and Simpson, 1961) and exponentially as arterial oxygen tension falls (Hume, 1968) . This increase may initially be beneficial because of increased oxygen-carrying capacity, since capacity increases linearly with increasing haemoglobin and P.C.V. Blood viscosity, on the other hand, increases exponentially with increasing P.C.V., rising very rapidly at over 600o (Dintenfass and Read, 1968) , and a point may therefore be reached at which further increases in red cell volume will not result in increased oxygen delivery to the tissues because of increasing viscosity and decreasing tissue blood flow. Dintenfass and Read also argued that hypoxia and acidosis may markedly increase blood viscosity at any P.C.V., and this will be an important additional factor in patients with hypoxic lung disease.
Polycythaemia imposes an additional strain on the heart in patients with pulmonary disease. Renzetti et al. (1966) found the incidence of right heart failure to be 53 8% in patients with P.C.V. over 54°h but only 16-4% in patients with P.C.V. below 54WI, and Mitchell et al. (1964) reported the adverse effect of a high P.C.V. on prognosis. Semmens (1971) found in necropsy studies on patients with chronic airways obstruction that all those with P.C.V. over 51 % have right ventricular hypertrophy.
There are several causes of right heart strain in these patients with lung disease, including increased pulmonary vascular resistance due to structural damage, hypoxia, and polycythaemia. These three factors contributing to raised pulmonary vascular resistance are clearly interrelated, but the isolated effect of P.C.V. has recently been found in dogs where pulmonary vascular resistance was shown to increase exponentially with increasing P.C.V. (Agarwal et al., 1970) . Other studies in dogs have shown that cardiac output falls as P.C.V. is increased (Sunder-Plassman et al., 1970) . Segal and Bishop (1966, 1967) showed that in patients with primary or secondary polycythaemia cardiac output at rest and on exercise increases from subnormal levels as P.C.V. is reduced, provided that blood volume is not markedly decreased by the treatment.
There are good theoretical, clinical, pathological, and experimental reasons therefore for supposing that a high P.C.V. and blood viscosity in patients with hypoxic lung disease may be harmful and that reducing red cell mass in patients with secondary polycythaemia might be beneficial. Our results confirm that most patients with secondary polycythaemia benefit symptomatically from a reduction in red cell mass. Exercise tests mirrored the improvement in subjective exercise tolerance in four patients but not in one other. There were no changes in spirometry and no consistent changes in blood gas tensions, though transfer factor did increase in five of the seven patients in whom it was measured, as it did in four patients of Chamberlain and Millard (1963) .
There is a poor correlation between red cell volume and P.C.V. in patients with secondary polycythaemia, because the plasma volume may be raised, normal, or low, as it was in our patients. Pseudopolycythaemia may also occur in patients with lung disease. Therefore it is difficult to suggest a level of P.C.V. above which exchange transfusion is of benefit. We believe it to be of value in patients with a P.C.V. over 60%. All our patients in this group (Cases 4a, 4b, 6a, 7, and 8) improved symptomatically and were enthusiastic about the improvement. We also think that when the red cell volume is raised in patients with P.C.V. over 5500 exchange transfusion should be performed, as it was with benefit in Case 6b. In three of our patients the P.C.V. was between 50% and 5500. Each had a raised red cell volume and exchange transfusion benefited two (Cases 1 and 2), and in Case 2 the subjective increase in exercise tolerance was mirrored by an objective increase on the cycle ergometer. One patient (Case 5) did not improve. We conclude that some patients with P.C.V. between 50% and 55% who are truly polycythaemic will benefit from exchange transfusion. One of the female patients (Case 3) had a P.C.V. of 48 % with a red cell mass of 32-5 ml/kg. She remained so disabled after several weeks of physiotherapy, antibiotics, diuretics, and digoxin that a 1-litre exchange was performed. She improved both subjectively and objectively.
When P.C.V. and red cell mass are reduced to normal by exchange transfusion we have not had to perform a second exchange before six months. The P.C.V. and red cell mass were still raised after exchange in Case 6 and the patient was readmitted after 10 weeks with an exacerbation of heart failure, and further exchange transfusion was performed. We are now exploring the use of nocturnal oxygen at home to determine whether this will reduce the rate of increase in red cell volume and P.C.V. 
Conclusion
The mortality rate in patients with polycythaemia secondary to hypoxic lung disease rises with decreasing FEV, (Renzetti et al., 1966; Burrows and Earle, 1969) , and patients with an FEV, below 0-75 1. have a five-year survival rate of only 25%. Hypercapnia and cardiac abnormalities affect prognosis adversely independently of their relation to air flow obstruction, and Baldwin et al. (1949) found that the four-year mortality of patients with cor pulmonale was 730%. All our patients are therefore in the poor-prognosis group. We consider that exchange transfusion is a rapid and safe method of reducing red cell mass, P.C.V., and blood viscosity and that this produces a worth-while amelioration of symptoms lasting about six months, after which exchange transfusion can be repeated.
Introduction
There are three basic determinants of peripheral blood flow: the perfusion pressure, the morphology of the vessels, and the viscosity of the blood. In the past attention has been focused almost exclusively on the first two. In more recent years an abnormally high blood viscosity has been found in a number of vascular and haematological diseases (Wells, 1966; Skovborg et al., 1968; Dintenfass, 1969; Dormandy, 1970 ). An abnormality of blood viscosity, rather than pathological changes in the vessels or the heart, may well be the more important aetiological factor in many diseases characterized by poor circulation. However, the exact relationship, in humans, between changes in the blood viscosity and blood flow has rarely been studied; it was one of the aims of the present investigation to measure this relationship. Changes in blood viscosity and blood flow were observed during intravenous infusions. One of the solutions used for the infusions was low-molecular-weight (L.M.W.) dextran, which enjoys a considerable vogue as a blood flow improver and has been thought to have a specific effect on blood viscosity. To assess whether this dextran alters blood viscosity simply by haemodilution or by a more specific effect the results were compared with another group of subjects who received an equal volume of Hartmann's solution.
Method
The whole blood viscosity, packed cell volume (P.C.V.), leg blood flow, as well as the arterial and venous blood pressures were measured in 19 patients receiving intravenous infusions before elective abdominal surgery. Patients with evidence of haematological or cardiovascular disease, on history or examination, were excluded from the study. Ten patients received 10% dextran in saline and 10 Hartmann's solution. One patient was given both solutions at different times. Measurements were made after premedication and before induction of anaesthesia. Initial readings, begun 60 minutes after premedication with papaveretum and scopolamine or pethidine and atropine, were repeated until a steady state had been reached, when a sample of venous blood was withdrawn and an intravenous infusion set up in the arm. Then 500 ml of the solution to be infused was given over a period of 10 to 20 minutes. At the end of the infusion another 10-ml venous blood sample was withdrawn and all the measurements were repeated. Further readings were taken 10 minutes later.
